IRWD
Ironwood Pharmaceuticals Inc
Price:  
1.94 
USD
Volume:  
3,432,759.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD Relative Valuation

-131.3%
Upside

As of 2025-02-13, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is (0.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.94 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -131.3%.

The range of the Relative Valuation is (0.60) - (0.61) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 38.8x - 46.5x 42.6x
Forward P/E multiples 32.4x - 39.9x 36.2x
Fair Price (0.60) - (0.61) (0.61)
Upside -130.8% - -131.7% -131.3%
1.94 USD
Stock Price
(0.61) USD
Fair Price

IRWD Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -110.46
2025-02-06 -126.05
2025-02-05 -137.09
2025-02-04 -141.64
2025-02-03 -136.12
2025-01-31 -152.04
2025-01-30 -149.44
2025-01-29 -241.70
2025-01-28 -246.90
2025-01-27 -246.90
2025-01-24 -241.05
2025-01-23 -244.95
2025-01-22 -241.70
2025-01-21 -246.25
2025-01-17 -237.80
2025-01-16 -245.60
2025-01-15 -243.00
2025-01-14 -237.15
2025-01-13 -244.95
2025-01-10 -257.30
2025-01-08 -297.58
2025-01-07 -294.33
2025-01-06 -292.38
2025-01-03 -293.03
2025-01-02 -281.34
2024-12-31 -287.83
2024-12-30 -284.58
2024-12-27 -289.13
2024-12-26 -298.23
2024-12-24 -299.53
2024-12-23 -298.23
2024-12-20 -289.13
2024-12-19 -252.10
2024-12-18 -224.81
2024-12-17 -229.36
2024-12-16 -224.16
2024-12-13 -229.36
2024-12-12 -231.31
2024-12-11 -239.75
2024-12-10 -241.70
2024-12-09 -258.59
2024-12-06 -222.86
2024-12-05 -217.01
2024-12-04 -230.66
2024-12-03 -230.01
2024-12-02 -235.20
2024-11-29 -228.71
2024-11-27 -238.45
2024-11-26 -228.71
2024-11-25 -217.66